TRACER PHARMA ApS: Financial statements 2020
CVR: 34090106
Source: annual report 2020, Danish Business Authority
01/05/2019 – 30/04/2020
TRACER PHARMA ApS (CVR 34090106) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 4,367,226 and a net result of DKK 455,381 compared with DKK -330,498 the year before. That is an increase of 44.3% compared with the year before. Equity in the 2020 report amounted to DKK 649,711. The solvency ratio was 25.7%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 4,367,226
- Profit/Loss
- DKK 455,381
- Equity
- DKK 649,711
- Total Assets
- DKK 2,527,522
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 4.4 mio. | 455 t. | 650 t. | 5 |
| 2019 | - | 3 mio. | -330 t. | 194 t. | - |
| 2018 | - | 3.3 mio. | 417 t. | 525 t. | 4 |
| 2017 | - | 2.5 mio. | 20 t. | 227 t. | 4 |
| 2016 | - | 3.1 mio. | 123 t. | 207 t. | - |
Official annual report
How creditworthy is TRACER PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout TRACER PHARMA ApS
TRACER PHARMA ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2011. The company has been dissolved on 28 November 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 5,203,816 and a net result of DKK 687,871 compared with DKK 1,705,344 the year before. Equity in the 2025 report amounted to DKK 867,174.